Navigation Links
ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community
Date:8/6/2008

Company expands beyond core business of discovery and safety services to meet the evolving needs of the drug discovery and development community

BOSTON and CLEVELAND, Aug. 6 /PRNewswire/ -- ChanTest, the world-leading provider of validated ion channel-expressing cell lines and services for drug-discovery and development applications, will make a selection of its fully validated cell lines available to researchers through a new Web site: http://www.chantestchannels.com. ChanTest Founder and CEO Arthur ("Buzz") Brown announced the new business offering today at the Drug Discovery & Development Innovative Technologies conference in Boston. ChanTest's initial launch will be of nine cell lines that the company has validated on the major ion channel platforms, including manual patch clamp, PatchXpress(R), QPatch, IonWorks(R), Quattro(TM), and FLIPR-Tetra(R). Optimization on all platforms is in progress. According to Dr. Brown, the company will expand the number of cell lines available during 2008 to 64.

"As the preeminent ion channel company, our goal is to serve all the ion channel needs of pharmaceutical and biotech customers -- from early functional screens for profiling drug candidates or ranking within profiles during the drug-discovery process -- to a complete set of in vitro GLP service products for cardiac risk assessment," said Dr. Brown. "However, some companies prefer to maintain testing in house. For those customers, we're pleased to offer a new way that researchers can benefit from ChanTest's ion channel expertise and exhaustive study of the characteristics of our ion channel library -- by purchasing our validated cell lines. We want to ensure that all researchers have the best opportunity to identify ion channels as pharmaceutically relevant targets and accelerate work on providing new drugs to those targets."

The nine initial validated cell lines available curren
'/>"/>

SOURCE ChanTest
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Drug Discovery Technology, Booth 839
2. ChanTest Launches Redesigned Web Site
3. ChanTest to Highlight Most-Comprehensive Range of Ion Channel Profiling Screens and Consultation Services at 14th Annual SBS Conference, Booth 1104
4. ChanTest to Highlight Expanded Ion Channel Testing Services for Preclinical Safety at ToxExpo, Including the Worlds Largest Catalog of Validated Ion Channels, Booth 2504
5. Ingenuity Systems Launches Analysis Services
6. Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors
7. iNutrition Launches New Fission Fruit Nutrition Bars
8. Shire Re-Launches ADHDSupport.com, a Virtual Road Map Providing Information, Tools and Practical Tips About Attention Deficit Hyperactivity Disorder (ADHD)
9. Mylan Launches First Generic Version of Antihypertensive Sular(R) ER in the United States
10. Ranbaxy Launches Omeprazole 40 mg Capsules
11. Sagent Pharmaceuticals Launches Ceftazidime for Injection, USP

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , LIBREVILLE, Gabon, December 2 /PRNewswi...rica: Everyone,s Problem and Heritage" , ...sity, 2-3 June 2010 the,Gabonese Republic is hosti...n) on the issue of safeguarding biological resourc...overnment and state leaders, ministers,scientific...
(Date:12/2/2009)... , SINGAPORE, Dec. 2 S*BI...s novel oral JAK2 inhibitor, SB1518, at The Americ...xposition in New Orleans. ,, Data will be prese...-escalation trial of SB1518 detailing its safety, ...PK/PD) profile in dose levels ranging from 100 to ...
(Date:12/2/2009)... , SHANGHAI, Dec. 2 /PRNewswire-Asia/ --...arkets are in turmoil and uncertainty is part of m...he pharma industry has been,relatively immune to t... a,vacation. , During the midst of the di...Johnson & Johnson inaugurated an R&D cente...
(Date:12/1/2009)..., INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-Fir...I ) today announced revenue guidance for the fourt... $57 million, as compared with $69 million for the...r 2008 results was the first of two installment pa...ed in fourth quarter 2008 results was a one-time $...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3
...ll forms of human cloning has been approved by the...lies and is headed for a full Assembly vote. State...ack with identical bills - SB 243 and AB 499 - tha...has drawn vigorous opposition from both the scient... ban if approved, would outlaw not only cloning fo...
..., a proposed ban on all forms of human cloning in ... embryos both for reproductive purposes and for wh...ic cloning, the making of a cloned embryo for the ...olating the bill if it were to become law would go.... , ,The bill was amended to exempt non-human clon...
...000 people who recently attended BIO 2005 in Phila...become a worldwide phenomenon but its also becomin...nds me of how rock n roll became mainstream in the... it, the launch of the Beatles on the Sunday night...re to stay. So is biotech! , ,Within the first 15 ...
Other Biology Technology:Cloning ban too broad, stem-cell researchers argue 2Cloning ban too broad, stem-cell researchers argue 3Cloning ban too broad, stem-cell researchers argue 4Biotech phenomenon becoming mainstream in world economy 2Biotech phenomenon becoming mainstream in world economy 3Biotech phenomenon becoming mainstream in world economy 4Biotech phenomenon becoming mainstream in world economy 5
(Date:12/2/2009)... HOBOKEN, NJ According to the National Institute ...iagnosed with diabetes already have some stage of ...e to the retina caused by leaky blood vessels, is ... and is one of the most feared diabetic complicati...o,ve had diabetes for 10 years or more will experi...
(Date:12/1/2009)... OptiNose is pleased to announce the publication o...gating the efficacy and tolerability of its novel,...eatment of chronic rhinosinusitis with nasal polyp...rnational and European Rhinologic Societies. , ...nic disease that can significantly reduce a patien...
(Date:12/1/2009)...available in German . , Brown adipose tissue ...s of mitochondria, miniature power stations which... they normally generate a voltage similar to that ...lar processes. However, the mitochondria of brown ... ahead all the time. The energy released when the ...
Breaking Biology News(10 mins):Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 2Study shows pine bark improves circulation, swelling and visual acuity in early diabetic retinopathy 3New data on highly effective treatment for chronic rhinosinusitis with nasal polyps 2Brown fat cells make 'spare tires' shrink 2ResMed Acquires Laboratoires Narval 5240 1ResMed Acquires Laboratoires Narval 5240 2ResMed Acquires Laboratoires Narval 5240 3GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT 28TM 29 5235 1GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT 28TM 29 5235 2GlaxoSmithKline Receives Unanimous FDA Panel Approval Recommendation for VOTRIENT 28TM 29 5235 3Mediterranean Diet May Help Prevent Depression 58895 1Mediterranean Diet May Help Prevent Depression 58895 2Mediterranean Diet May Help Prevent Depression 58895 3
...team based at Massachusetts General Hospital (MGH)...ess of RNA interference (RNAi), a powerful new res...mals. They used the RNAi process itself to find ne...hanism, which someday may help to fight human dise... and is receiving early online release on the Scie...
...University Health Center (MUHC) in Montreal is ple...ada resulting from frozen eggs. A team led by Prof...stetrics and Gynecology at McGill University and D...UHC in Montreal confirmed the birth of a healthy b...he first in-vitro fertilization (IVF) Centre in Ca...
...es Medical Institute researchers chiseling away at...etailed explanation of how the drugs, main cellula...o some of these medications. The findings are alre...re being engineered to circumvent resistance, whic...omas A. Steitz, a Howard Hughes Medical Institute ...
Other Biology News:Scientists identify genetic pathways essential to RNA interference 2Scientists identify genetic pathways essential to RNA interference 3First frozen egg baby born in Canada 2First frozen egg baby born in Canada 3Researchers make gains in understanding antibiotic resistance 2Researchers make gains in understanding antibiotic resistance 3
Acridine orange, hemizinc salt from Research Organics, Inc.
Sf9 Insect Cells from BD Biosciences Pharmingen
Acridine orange 10-nonyl bromide from AnaSpec
HistoScan AP Universal Goat Kit from Biomeda Corporation
Biology Products: